-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_executive.pdf
November 01, 2013 - Test Performance and Optimal Decision Cutpoints. … Determinants Affecting Test Performance. … Test Performance and Optimal Cutpoints. … Determinants Affecting Test Performance. … This should provide users of the
test with robust information on the applicability of the
test to patients
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
January 01, 2011 - Different forms of iron-deficiency
anemia could affect the diagnostic test performance of iron-status … What reference standards are used for the diagnosis of iron status in studies evaluating
test accuracy … Question 4
What factors affect the test performance and clinical utility of newer markers of iron … affecting the diagnostic test performance and the effectiveness of test-oriented treatments (KQ
4) … We will test the forms on several studies and revise as necessary before full data extraction.
-
effectivehealthcare-admin.ahrq.gov/products/alzheimers-type-dementia/research
October 01, 2022 - Purpose of Review To summarize evidence on cognitive test accuracy for clinical Alzheimer’s-type dementia … Cognitive test accuracy studies must have used explicit CATD diagnostic criteria and a non-CATD control
-
effectivehealthcare-admin.ahrq.gov/products/c-diff-infections/research-protocol
December 01, 2019 - for toxins if the first step test is positive. … Physicians may not always be sufficiently educated as to which diagnostic test is best to use and how … best to resolve a suspected false negative result (e.g., evidence suggests retesting with the same test … Outcomes for each question:
Diagnostic Test Outcomes
Sensitivity
Specificity
Predictive values … Timing:
Diagnostic testing: time to test
Antibiotic and non-standard treatments: variable, generally
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0713-140625.pdf
January 07, 2014 - interested in the adverse effects of pharmacotherapy
treatment options, and patient characteristics or test … effects of pharmacotherapy
treatment options; a better understanding of the patient characteristics or test … What are the patient characteristics or test results that can be used to determine
the optimal pharmacotherapy
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
December 01, 2009 - Studies of diagnostic test performance compare the
results of the experimental test to a reference test … The
reference test is intended to measure the “true” disease
status of each patient. … Studies of diagnostic test performance were examined
to see if they met the inclusion criteria. … In general, the
smaller the negative likelihood ratio, the more accurate
4
the diagnostic test is … However, each individual woman’s post-test
risk varies by her individual pre-test risk of malignancy.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatic-fibrosis_white-paper.pdf
April 01, 2014 - No test for which we
obtained additional data was originally rated low strength of evidence. … No test for which we obtained additional data was
originally rated low strength of evidence, where … Comparison of test performance profile for
blood tests of liver fibrosis in chronic
hepatitis C. … How to
use an article about a diagnostic test. B. … Genet Test Mol Biomarkers.
2012 Jun;16(6):531-5. PMID: 22352690.
63.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_disposition-comments.pdf
August 23, 2012 - This conundrum exemplifies the challenges
surrounding evaluation of a test in monoclonal disorders. … This was done to allow for a comparison of test accuracy
among patients that were not preselected as … “Hospital stays” may be an unrealistic outcome to
measure for a laboratory test (would performing a … Site as a future light chain test for
evaluation. … Finally, it is the most useful test in patients with
amyloidosis.
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/does-the-use-of-cytochrome-p450-2c19-cyp2c19-testing-to-predict-response-to-clopidogrel-in-people-1-with-acute-coronary-syndrome-2-who-have-suffered-other-cardiovascular-disease-related-events-eg-ischemic-stroke-symptomatic-
November 01, 2017 - Briefly describe a specific question, or set of related questions, about a health care test … coronary intervention, lead to improvements in health outcomes compared to a no-testing strategy, or are test
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0332_07-29-2010.pdf
January 01, 2010 - active treatment)
lead to improvements in health outcomes compared to a no-testing strategy, or are
test … Errors in test assay leading to inaccurate results.
b. … This test is already being marketed and there is a critical need for an understanding of how this
marker
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0411_02-10-2011.pdf
January 01, 2011 - time/partial thromboplastin time, basic or complete metabolic
panel, urinalysis, and urine pregnancy test … (e.g., potassium in patients on diuretics, pregnancy test in
women of child-bearing age)
4.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_disposition-comments.pdf
February 13, 2012 - We did calculate the positive likelihood ratios and used
those to illustrate post-test probability of … disease across a range of
pre-test probabilities. … Non-
invasive test such as MRI have unknown long term risk of Gd
exposure and PET, BSGI and MIBI have … Analytical framework schema
(page 27) indicates the non-invasive diagnostic test would
occur after … If an available non-invasive
diagnostic test could assist clinicians in evaluating women....
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
November 20, 2014 - Estimates of test performance should incorporate information from
all sources. … and the other imaging test in the
same patients. … So the test of choice is heavily dependent on the clinical
situation. … accuracy
Our own report was restricted to test accuracy studies that
examined comparative test performance … All of these
studies used PET/CT, compared test accuracy of PET/CT vs.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/c-diff-infections_executive.pdf
December 01, 2011 - Direct comparisons of
diagnostic tests without a reference test were not
included. … We included
initial cure, recurrence (variably defined by symptoms
with or without a positive test for … Otherwise, there was only low-strength evidence for or
against differences in test specificities. … There was moderate
evidence that the test specificities in one comparison
did not differ. … Bayes’ formula, then the
differences in post-test probabilities might not lead to
different clinical
-
effectivehealthcare-admin.ahrq.gov/health-topics/biopsy
December 06, 2016 - In most cases, a biopsy is the only test that can tell for sure if a suspicious area is cancer.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
April 01, 2013 - structure and function of
the right heart in patients with pulmonary hypertension.7
However, this test … Therefore, although
transthoracic echocardiography is the standard screening
test for PAH, it is less … NT-proBNP) are two biological
substances found in the blood that have been studied as
a screening test … Thirty-four
studies used RHC as a reference test, 15 studies used
6MWD as a reference test, and 10 … studies used FC as a
reference test.
-
effectivehealthcare-admin.ahrq.gov/products/cancer-communication/research
November 01, 2017 - Objectives
The goal of Phase 2 was to refine the Phase 1 framework; identify, develop, and test PCC … Develop and Test Measures : We developed an inventory of PCC survey items by examining published literature … needed to finalize the items including additional cognitive testing, conducting a large-scale field test
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
April 20, 2015 - Risk: Low/High/Unclear
Domain 2: Index Test(s) (complete for each index test used)
Were the index … test results interpreted without knowledge of the reference standard? … Methods to detect publication bias for
medical test studies are not robust. … Chapter 8: meta-analysis of test
performance when there is a "gold standard". … Methods Guide for Medical Test
Reviews.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
July 23, 2012 - This excerpt comes from
an article, “Cancer Society Casts Doubt on Value of
Prostate
Cancer Test … initially chose active surveillance after positive results from
a
prostate-‐specific
antigen
test … School of Medicine, tells his physician not to order a PSA
[prostate-‐specific
antigen]
blood test … or an annual electrocardiogram
since
neither test has
been
shown
to
save
lives … posted
on its
blog:
“…[O]ur greatest fear was that forces with an economic interest in the test
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_appendixes.pdf
January 01, 2009 - Sweat Test: A standard diagnostic test for cystic fibrosis that measures the concentration of
chloride … Until death
or Dec 1984
Student’s t test
or Chi-square
test and Cox
proportional
hazards model … Until death or
Dec 1984
Student’s t test or
Chi-square test and
Cox proportional
hazards model … Until death or
transplant by
July 1993
Student’s t
test
6 minute
walk test
MD -101.7 m
NS … NR Student’s t
test
6 minute
walk test
MD -43 m
(95%CI
-53.23,
139.23)
NR
F-18